The U.S. leads in female mortality due to musculoskeletal and connective tissue diseases, with a 2.28% increase in 2023, while Japan and Mexico also saw notable rises. Colombia experienced the largest reduction at 6.74%. Countries like Poland (3.47%) and Portugal (3.55%) showed significant increases. Conversely, reductions were seen in Slovakia and Romania, each over 5%. The data indicates mixed trends globally with wide variations among countries.
Future trends to watch include the impact of medical advancements, aging populations, and lifestyle changes on mortality rates in various countries. Continued monitoring of these factors will be crucial for anticipating healthcare needs and resource allocation.
Top countries in Musculoskeletal System and Connective Tissue Diseases Mortality by Country
| # | 10 Countries | Units (Female Deaths) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 9,510 | 2023 | +0.89% | +2.28% | View data |
| 2 | 2 Japan | 5,970 | 2023 | +2.82% | +2.1% | View data |
| 3 | 3 Brazil | 4,210 | 2023 | +1.96% | +1.86% | View data |
| 4 | 4 Mexico | 3,740 | 2023 | +1.16% | +2.68% | View data |
| 5 | 5 Spain | 3,520 | 2023 | +1.65% | +0.18% | View data |
| 6 | 6 United Kingdom | 2,650 | 2023 | +0.19% | -1.14% | View data |
| 7 | 7 South Africa | 1,380 | 2023 | +1.47% | +1.02% | View data |
| 8 | 8 Canada | 1,340 | 2023 | +1.21% | +1.61% | View data |
| 9 | 9 Colombia | 1,170 | 2023 | -2.25% | -6.74% | View data |
| 10 | 10 Australia | 947 | 2023 | +1.28% | +2.52% | View data |
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...
